What to know about prostate cancer prevention and treatment

Understand the latest in prostate cancer screening, prevention strategies, and developments in treatment.

a young doctor speaks with a male patient

Updated on April 1, 2024.

After skin cancer, prostate cancer is the most common cancer type and the number two cause of cancer death among men in the United States. Because of it's so common, scientists have been working hard in recent years to improve screening methods, treatments, and outcomes for people with prostate cancer.

“Prostate cancer research is an exciting field because we’re seeing so many advancements,” says Shaw Zhou, MD, a urologist at Northside Hospital in St. Petersburg, Florida. More and newer forms of therapies for prostate cancer are making treatment more advanced.

The prostate is a male reproductive organ that makes semen and sits below the bladder. With all the latest developments, it can be difficult to know which treatments may actually benefit someone with prostate cancer. Here’s how to make sense of the key issues.

Do supplements prevent prostate cancer?

There’s no known way to prevent prostate cancer, but you may have read about foods or supplements that can help lower your risk.

“You see prostate supplements and fad diets in the media all the time,” says Dr. Zhou. “Be sure to discuss these with your healthcare provider (HCP) before trying them.”

A dose of skepticism is warranted. There’s not always enough evidence to determine whether a supplement claiming to help with prostate health is safe and effective. Even if something seemed to work in a study, it may not be right for you. 

For example, taking supplements containing the mineral selenium was once thought to be potentially beneficial. But a large 2009 study in JAMA—and its follow-up in 2014—suggested selenium was linked to more aggressive prostate cancer that grows and spreads faster in men who were already diagnosed. Now, many healthcare providers (HCPs) recommend people with the disease avoid selenium supplements.

Be especially wary of multivitamins that claim to have cancer-fighting abilities. There is no strong evidence that multivitamins increase or decrease your risk of prostate cancer.

Always check with your HCP before adding dietary supplement and vitamins to your daily regimen.

What might help reduce prostate cancer risk?

Results from some studies have provided suggestions that may help reduce prostate cancer risk. These include:

  • Enjoy a daily cup of coffee. Men who drank more coffee were significantly less likely to develop prostate cancer in a 2021 analysis published in the journal BMJ Open.
  • Cook with tomatoes. Tomatoes contain lycopene, an antioxidant plant compound which might prevent cell damage caused by free radicals (an unstable moolecule created as a result of natural body functions, such as metabolism). Men with diets rich in lycopene had lower rates of prostate cancer and fewer instances of late-stage prostate cancer, according to a 2020 study published in Biomedicine & Pharmacotherapy. It should be noted, however, that few studies have linked tomato consumption to lower prostate cancer risk.
  • Include soy foods in your diet. There are few studies on this topic, but a study published in 2018 in the journal Nutrients suggested that the phytoestrogens, or estrogen-like plant substance found in soy, block the male hormones that contribute to prostate cancer.

Increasing evidence also suggests that reducing your intake of meat can help lower your risk of prostate cancer.

What to know about the PSA test

The prostate specific antigen (PSA) blood test is used for prostate cancer screening. If your PSA level is high, your HCP may recommend additional testing to check for prostate cancer.

The decision to have the PSA test should be made after discussing the pros and cons with your HCP. Keep in mind that the PSA isn’t always reliable. Your level could go up if you have an enlarged prostate or an infection. Another factor to consider: The PSA doesn’t always go up when someone actually has cancer.

The United States Preventive Services Task Force (USPSTF) recommends that men between the ages of 55 and 69 should make an informed, personal decision with their HCP about whether to get the PSA test. The USPSTF advises against screening for prostate cancer if you’re over 70. People at a higher risk of prostate cancer, including Black individuals and those with a family history of the disease, should speak with an HCP about screening at an earlier age. 

What to know about prostate cancer screening

A PSA test alone is not entirely reliable for diagnosing prostate cancer.

“With the PSA, it’s not like a pregnancy test where you get a positive or a negative result, and then you have an answer,” says Zhou. “Instead, you have to consider a whole spectrum of risk factors to decide whether you’ll do more testing.” These factors include age, race, weight, and medical history.

That’s why many HCPs are now putting together a more complete picture using precision medicine, rather than looking at the PSA alone, Zhou explains. Precision medicine takes into account a person’s genes, their lifestyle, and their medical history to better tailor treatment decisions to them. Precision medicine tests include:

  • 4Kscore: This test system measures four proteins in a patient’s blood to evaluate their likelihood of aggressive prostate cancer that grows and spreads more quickly. It also takes into consideration factors like age, medical history, and the results of a digital rectal exam (when an HCP inserts a gloved, lubricated finger into the rectum to check the prostate).
  • Prostate Health Index (phi): This is a combination of three blood tests that provides information on the likelihood of finding cancer that would require treatment.
  • Gene testing: Testing certain genes, including breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2), is recommended for people who have a family history of cancer and may be at higher risk for prostate cancer, according to National Comprehensive Cancer Network guidelines. 
  • ExoDx Prostate IntelliScore (EPI): This is a test that looks at levels of three substance in urine to find out the risk for aggressive prostate cancer in people 50 years and older who have a certain amount of PSA in their blood.

Your HCP may recommend you get these tests if your PSA level is uncertain or you’re trying to decide whether or not to receive cancer treatment.

What to know about prostate cancer treatment

To confirm that you have cancer and determine how advanced it is, you’ll likely need a biopsy. A biopsy involves using a needle to remove a sample of prostate tissue, which is then sent to a lab for testing under a microscope.

If your biopsy reveals that you have cancer, you may opt for surgery to remove your prostate. “Currently, many prostate removals are done with minimally invasive robotic surgery,” says Zhou. “The newest generation of robots has improved tremendously. They’re easier to move and operate on the very small level that surgeons need to work.”

Most people have a number of treatment options available in addition to surgery. “Again, precision medicine is making treatment very specific to the individual,” says Zhou. “For example, immunotherapy involves using your own immune system—your own white blood cells—to treat the cancer.” Other treatment approaches include:

  • Active surveillance: Prostate cancer is often slow-growing and many people live with it for years or decades without needing treatment. Active surveillance involves making routine visits to your HCP for blood tests and, possibly, for additional biopsies to monitor the cancer.
  • Radiation therapy: High-energy x-rays are directed at your prostate or small pieces of radioactive substances are placed inside the prostate to kill cancer cells.
  • Cryotherapy: This procedure uses very cold temperatures to freeze and kill prostate cancer cells. It's sometimes used if prostate cancer comes back after radiation.
  • Hormone therapy: For most prostate cancer cells to grow, male sex hormones called androgens need to attach to part on the prostate cancer cell called an androgen receptor. Anti-androgen drugs (also called androgen deprivation therapy) connect to these receptors, preventing androgen hormones from causing tumors to grow.
  • Chemotherapy (chemo): This approach uses drugs that attack cancer throughout the body. It's sometimes used if cancer has spread beyond the prostate gland and hormone therapy isn't enough to treat it.
  • Targeted therapy: Unlike chemo, which affects the whole body, newer forms of treatment target cancer cells while leaving healthy cells alone.
  • Adjuvant therapy: For people with high-risk prostate cancer, additional treatment called adjuvant therapy can be used after the first treatment has been received, which may improve response to treatment

To help develop a treatment plan that makes the most sense for you, talk with your HCP to discuss all your options, ask about risks and benefits, and get any questions about insurance coverage answered.

Article sources open article sources

Centers for Disease Control and Prevention. Prostate Cancer: Prostate Cancer Statistics. Last reviewed June 8, 2023.
American Cancer Society. Key Statistics for Prostate Cancer. Last Revised: January 12, 2022.
National Cancer Institute. Prostate Cancer, Nutrition, and Dietary Supplements (PDQ)–Patient Version. Updated May 11, 2022.
Kenfield SA, Van Blarigan EL, DuPre N, et al. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2014 Dec 12;107(1):360. 
American Cancer Society. What’s New in Prostate Cancer Research? Last Revised: October 8, 2021.
American Cancer Society. Can Prostate Cancer Be Prevented? Last Revised: June 9, 2020.
Brasky TM, Darke AK, Song X, et al. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial, JNCI: Journal of the National Cancer Institute, Volume 105, Issue 15, 7 August 2013, Pages 1132–1141.
Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556.
Chen X, Zhao Y, Tao Z, et al. Coffee consumption and risk of prostate cancer: a systematic review and meta-analysis BMJ Open 2021;11.
Mirahmadi M, Azimi-Hashemi S, Saburi E, et al. Potential inhibitory effect of lycopene on prostate cancer, Biomedicine & Pharmacotherapy, Volume 129, 2020, 110459.
Applegate CC, Rowles JL, Ranard KM, et al. Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Nutrients. 2018;10(1):40. Published 2018 Jan 4.
Prostate Cancer Foundation. Less Meat, Less Prostate Cancer? March 8, 2022.
You W, Henneberg M. Prostate Cancer Incidence is Correlated to Total Meat Intake– a Cross-National Ecologic Analysis of 172 Countries. Asian Pac J Cancer Prev. 2018;19(8):2229-2239. Published 2018 Aug 24.
Wolff T, Jadotte YJ. American Screening for Prostate Cancer. Am Fam Physician. 2018;98(8):537-538.
Biddle C, Brasel A, Underwood W 3rd, Orom H. Experiences of Uncertainty in Men With an Elevated PSA. Am J Mens Health. 2017 Jan;11(1):24-34. 
U.S. Food & Drug Administration. 4Kscore Test – P190022. January 18, 2022.
American Cancer Society. Screening Tests for Prostate Cancer. Last Revised: January 4, 2021.
U.S. Preventive Services Task Force. Prostate Cancer: Screening. May 08, 2018.
National Cancer Institute. Genetics of Prostate Cancer (PDQ®)–Health Professional Version. Updated: March 17, 2023.
Memorial Sloan Kettering Cancer Center. Prostate Cancer Diagnosis. Accessed February 10, 2022.
Margolis E, Brown G, Partin A, et al. Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):296-301. 
American Cancer Institute. Cryotherapy for Prostate Cancer. Last Revised: August 1, 2019. American Cancer Society. Hormone Therapy. Last Revised: September 23, 2021.
American Cancer Society. Targeted Therapy for Prostate Cancer. Last Revised: June 10, 2020.
National Cancer Institute. Adjuvant Chemotherapy Modestly Improves Survival in Some Men with Prostate Cancer. June 8, 2015.
URO Today. ASCO 2023: Timing of PARP Inhibition for Prostate Cancer with Defects in Homologous Recombination Repair. 

More On

Study reveals prostrate cancer diagnosis, outcomes for men by races

video

Study reveals prostrate cancer diagnosis, outcomes for men by races
Black men are two times more likely to develop prostate cancer than white men, study says. Early diagnosis and treatment resulted in similar outcomes ...
What is castration-sensitive prostate cancer?

article

What is castration-sensitive prostate cancer?
Understanding and treating prostate cancer that responds to androgen-deprivation therapy.
How Are Prostate Cancer and Cardiovascular Disease Related?

video

How Are Prostate Cancer and Cardiovascular Disease Related?
Prostate cancer and CVD are related. In this video, Dr. Christopher Vaughn, Host of Cancer Shop Talk: Behind the Diagnosis with Dr. Vaughn, explains h...
What you need to know about prostate cancer

article

What you need to know about prostate cancer
It’s the second most common cancer in men. Learn the prostate cancer facts, including symptoms and risk factors.
What is the treatment for metastatic prostate cancer?

article

What is the treatment for metastatic prostate cancer?
The medications used to treat prostate cancer that has spread to other areas of the body.